Aspirin for Exercise in Multiple Sclerosis (ASPIRE)

Clinical trial NCT03824938 · COMPLETED

Trial details

NCT number: NCT03824938
Sponsor: Columbia University
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2019-04-30
Primary completion: 2022-02-28
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.